Detailed price information for West Pharmaceutical Services (WST-N) from The Globe and Mail including charting and trades.

Opportunities in the pharmaceutical industry include innovation in biologics, growth in GLP-1 therapies and precision oncology, rising demand for advanced treatments, and expanding manufacturing in ...

This briefing outlines recent developments in the health sector, highlighting West Pharma's profit rise, Amneal's acquisition deal, Elevance Health's cost controls, and Thermo Fisher's strong results.

In today’s Pharmaceutical Executive Daily, UnitedHealth raises its full-year profit forecast following stronger-than-expected ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

From Eli Lilly revealing its fourth new manufacturing site in a $27 billion capital investment spree in the US – a $3.5 billion facility in Lehigh Valley, Pennsylvania – to the FDA starting to accept ...

"At Clin Ops Solutions, we recognized that the industry doesn't just need connections--it needs meaningful conversations and shared insight," said Sylvain Bédard, Founder and CEO ...

Key market opportunities in the oral transmucosal drugs sector include expanding use in opioid dependence, seizures, and pain management, driven by needle-free dosing preference and film technology ...

A new market analysis projects a compound annual growth rate of 9.8%, driven by the expanding biologics pipeline and a ...

Key market opportunities in the RNA extraction and purification sector include the growing demand for RNA-based therapies and diagnostics, the development of user-friendly and automated kits, and the ...

Dr. Reddy's Laboratories jumps 7% as NIFTY Pharma rises 2.33%. Explore key reasons behind the rally, including rupee weakness, export gains, and defensive sector rotation.

Fierce Biotech has released its annual ranking of the top 10 pharma R&D budgets of 2025—offering a clear look at which ...